Drug Trial Radar · NCT07690826
A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity
Last checked: Nov 20, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
252
Planned (sponsor's estimate)
Start
Jul 2026
Primary completion
Mar 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled Phase II study to evaluate the efficacy and safety of once-weekly HRS-4729 injection in adults with obesity without diabetes. Approximately 252 participants will be enrolled. The primary endpoint is percent change in body weight from baseline at Week 32 versus placebo.
Conditions
- Overweight or Obesity
Interventions
HRS-4729 InjectionDrug
HRS-4729 Injection; Dose 1
HRS-4729 InjectionDrug
HRS-4729 Injection; Dose 2
HRS-4729 InjectionDrug
HRS-4729 Injection; Dose 3
HRS-4729 Injection;Drug
HRS-4729 Injection; Dose 4
HRS-4729 Injection;Drug
HRS-4729 Injection; Dose 5
HRS-4729 Injection;Drug
HRS-4729 Injection; Dose 6
HRS-4729 Injection PlaceboDrug
HRS-4729 Injection Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Body WeightTime frame: Baseline, Week 32
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.